D
Ascendis Pharma A/S ASND
$164.65 -$4.19-2.48%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 185.39M 63.58M 38.75M 104.10M 148.25M
Total Other Revenue -- -- -- -- --
Total Revenue 185.39M 63.58M 38.75M 104.10M 148.25M
Cost of Revenue 14.95M 12.31M 12.34M 8.22M 20.95M
Gross Profit 170.44M 51.27M 26.41M 95.88M 127.30M
SG&A Expenses 85.51M 76.77M 79.98M 72.50M 68.87M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 184.98M 169.94M 182.18M 157.45M 187.66M
Operating Income 408.30K -106.36M -143.43M -53.35M -39.41M
Income Before Tax -39.85M -107.93M -117.48M -139.53M -87.30M
Income Tax Expenses 1.16M 1.12M 246.50K 2.72M 6.23M
Earnings from Continuing Operations -41.01M -109.06M -117.73M -142.25M -93.53M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -41.01M -109.06M -117.73M -142.25M -93.53M
EBIT 408.30K -106.36M -143.43M -53.35M -39.41M
EBITDA 1.72M -101.55M -138.71M -48.49M -37.65M
EPS Basic -0.69 -1.90 -2.05 -2.50 -1.65
Normalized Basic EPS -0.42 -1.17 -1.28 -1.53 -0.96
EPS Diluted -0.69 -1.90 -2.05 -2.50 -1.65
Normalized Diluted EPS -0.42 -1.17 -1.28 -1.53 -0.96
Average Basic Shares Outstanding 59.79M 57.54M 57.35M 56.88M 56.56M
Average Diluted Shares Outstanding 59.79M 57.54M 57.35M 56.88M 56.56M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings